These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Droperidol for the treatment of acute peripheral vertigo. Irving C; Richman PB; Kaiafas C; Eskin B; Ritter A; Allegra J Am J Emerg Med; 1999 Jan; 17(1):109-10. PubMed ID: 9928721 [No Abstract] [Full Text] [Related]
4. The effect of thiethylperazine on nausea, vomiting and vertigo. Flock ER; Royce RD; Buller RL; Ingram MH J Okla State Med Assoc; 1966 Sep; 59(9):515-9. PubMed ID: 5341353 [No Abstract] [Full Text] [Related]
5. A double-blind, placebo-controlled study of Ru-Vert in patients with vertigo. Pou JW; Quinn HJ Curr Ther Res Clin Exp; 1967 Nov; 9(11):558-62. PubMed ID: 4965504 [No Abstract] [Full Text] [Related]
6. Metoclopramide for vertigo. Salas JR N Z Med J; 1967 Dec; 66(425):870-2. PubMed ID: 5236016 [No Abstract] [Full Text] [Related]
8. Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo. Canty P; Valentine J J Laryngol Otol; 1981 Jul; 95(7):687-92. PubMed ID: 7019369 [No Abstract] [Full Text] [Related]
9. [Recent research on vertigo. Clinical and nystagmographic study]. Jost G; Danon J Therapeutique; 1969 Apr; 45(4):402-3. PubMed ID: 4916576 [No Abstract] [Full Text] [Related]
10. A controlled clinical study of metopimazine and perphenazine in treatment of radiation nausea and vomiting. Chu FC; Paulshock M; Wallenstein SL; Houde RW; Phillips R Clin Pharmacol Ther; 1969; 10(6):800-9. PubMed ID: 4900201 [No Abstract] [Full Text] [Related]
11. [Clinical study of Dogmatil action on vertigo by the double blind method]. Semette D JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1972 Jan; 21(1):75-6. PubMed ID: 4260530 [No Abstract] [Full Text] [Related]
12. [Clinical and electronystagmographic experience with a new drug containing cinnarizine in the treatment of vertigo]. Castellini V Boll Mal Orecch Gola Naso; 1969; 87(2):107-31. PubMed ID: 4394485 [No Abstract] [Full Text] [Related]
13. Evaluation of diphenidol in the symptomatic treatment of labyrinthine vertigo. Corvera J; Torres G; Zepeda I Eye Ear Nose Throat Mon; 1970 Apr; 49(4):190-4. PubMed ID: 5481604 [No Abstract] [Full Text] [Related]
14. [Clinical experimentation with a new anti-vertigo and anti-nausea drug: R.306]. Bossut Y; Deguine C; Decroix G Lille Med; 1970 Nov; ():Suppl 6:1353+. PubMed ID: 5502910 [No Abstract] [Full Text] [Related]
15. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin. Oosterveld WJ Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617 [TBL] [Abstract][Full Text] [Related]
16. Labyrinthine vertigo: symptomatic treatment with diphenidol. Smoot AC Del Med J; 1965 Oct; 37(10):234-7. PubMed ID: 5831499 [No Abstract] [Full Text] [Related]
17. [Double blind test of the effect of sulpiride. A new antivertiginous agent]. Mathisen R; Sveen K Tidsskr Nor Laegeforen; 1976 Aug; 96(23):1200-2. PubMed ID: 788226 [No Abstract] [Full Text] [Related]
18. Flunarizine in vertigo. A double-blind placebo-controlled cross-over evaluation of a constant-dose schedule. Oosterveld WJ ORL J Otorhinolaryngol Relat Spec; 1982; 44(2):72-80. PubMed ID: 7041040 [TBL] [Abstract][Full Text] [Related]
19. [Value of a new drug in the control of various functional disorders in otorhinolaryngologic surgery]. Bouny PB Sem Ther; 1968 Feb; 44(2):102-3. PubMed ID: 5744005 [No Abstract] [Full Text] [Related]
20. The laboratory assessment of anti-motion sickness and anti-vertigo drugs. Barber HO; Basser W; Johnson WH; Takahashi P Can Med Assoc J; 1967 Dec; 97(24):1460-5. PubMed ID: 4863013 [No Abstract] [Full Text] [Related] [Next] [New Search]